Six core products, multiple therapeutic SKU's from (a) the flower (b) leaf oil (c) seed oil, (omega) (d) hydrosol (e) phenolic compounds, (f) the bark (tannins)
.
This shifts the narrative from a single commercial product to a biocultural, biodiverse, scientifically rich ecosystem built on a “whole of tea-tree” system

Our international distribution model follows the "ICANN" (Internet Corp for Assigned Network Names) plus the OIC global, regional structures. It provides for one company to hold the master distribution rights per region, bundled with equity in the holding company that targets an SX listing

GDP estimated at USD33T. California based Tribal Therapeutic Corp is the Master Distributor for the 29 economies that comprise the ARIN region.

GDP estimated at USD7T. Initially to be serviced through the ARIN region until demand requires the appointment of a Master Distributor for the region.

GDP estimated at USD40T. As the product source, AU-NZ will be excluded from any distribution arrangement. Ideally based in (a) Singapore, (b) Hong Kong or (c) Malaysia

GDP estimated at USD21T. (MENA region excluded from the total of 76 countries in the RIPE region). As the UK is not an EU member, Germany is the preferred distribution base.

GDP estimated at USD3T. Due to the economic reach of the MENA region, regional distribution provides for the African continent's Master Distributor to be MENA based.

GDP estimated at USD9T. To launch via an OIC Regional Distributor based in Malaysia through an equity-licensed "Halal Hub" based, JAKIM certified manufacturer.

Supporting the Series A & B Rounds that follow.

Conditions do apply
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.